FINHUB Insights

ZBH · Q3 FY25 · Jul 1 – Sep 30, 2025

Zimmer Biomet Q3 FY25: where the revenue came from and where it went

Zimmer Biomet Q3 FY25: revenue $2B (+10% year over year). Net profit $0.2B. Largest cohort Knees $0.8B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Nov 5, 2025 10-Q
Sankey diagram of Zimmer Biomet's income statement for Q3 FY25: revenue of $2 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2B +10% year over year
Gross profit$1.4B 72% margin
Operating profit$0.4B 18% margin
Net profit$0.2B 12% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 2 100% +10%
Knees 0.8 40% +6%
SET 0.5 25% +19%
Hips 0.5 25% +5%
Technology and Data Bone Cement… 0.2 10% +12%
Cost of revenue−0.630%
Gross profit1.472% margin+2pp
SG&A−0.841%+2pp
Other−0.314%+0pp
Operating profit0.418% margin+2pp
Interest & other costs−0.2
Net profit0.212%−2pp
Filing on EDGAR More quarters of ZBH

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters